Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aptech Ltd. Regulatory Filings 2022

Jan 20, 2022

60838_rns_2022-01-20_45107399-df7c-40e8-9fe0-7c21c894e9ff.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Aptech Limited Regd. office: Aptech House A-65, MIDC, Moroi, Andheri (E), Mumbai - 400 093. T: 91 22 2827 2300 F: 91 22 2827 2399 www aptech-worldwide corn

==> picture [202 x 56] intentionally omitted <==

Unleash your potential

20[th] January, 2022

To, BSE Limited 25[th] Floor, P J Towers, Dalal Street, Mumbai – 400 001 Scrip Code: 532475 Email: [email protected]

To,

National Stock Exchange of India Limited Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex Bandra (E), Mumbai - 400 051. Symbol: APTECHT Email: [email protected]

Dear Sir/Madam,

Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

The Strategy Committee placed their recommendations before the Board on January 19, 2022 interalia advising the Board to consider and include Institutional business back under continued operations due to good turnaround performance in last one year. Institutional business in February 2021 was put up under discontinued operations from accounting perspective and its potential exit was envisaged. However, the Board upon considering the recommendations, decided to evaluate in detail, the aforesaid recommendation on Institutional Business and thereafter take an informed decision on the same in due course.

Thanking you Yours faithfully

For Aptech Limited

==> picture [74 x 44] intentionally omitted <==

A.K Biyani Company Secretary

==> picture [280 x 16] intentionally omitted <==